PedAM
Pediatric Disease Annotations & Medicines
| Disease | ovarian cancer |
| Symptom | C0948303|peritoneal carcinoma |
| Sentences | 14 |
| PubMedID- 23838915 | Methods: we retrospectively evaluated a consecutive series of 175 stage iiic-iv epithelial ovarian cancer patients, with diffuse peritoneal carcinomatosis documented at initial surgical exploration. |
| PubMedID- 26197773 | A total of 144 stage iiic ovarian cancer patients with peritoneal carcinomatosis treated from 1994 to 1998 were retrospectively reviewed. |
| PubMedID- 21039384 | The objective of this study was to evaluate if cytoreduction of peritoneal carcinomatosis in patients with chemorefractory recurrent ovarian cancer as salvage treatment confers any survival benefits. |
| PubMedID- 22709648 | Therefore, hipec after crs was proposed as the “up-front treatment” for ovarian cancer with peritoneal carcinomatosis . |
| PubMedID- 23948509 | Objectives: to investigate the role of whole-body fluorine-18-2-deoxy-2-fluoro-d-glucose positron emission tomography/computed tomography ((18)f-fdg pet/ct) in the identification of peritoneal carcinomatosis in patients with ovarian cancer (oc). |
| PubMedID- 24675485 | Patients treated showed abdominal malignancies and ovarian cancer with peritoneal carcinomatosis. |
| PubMedID- 22454640 | Preoperative diagnosis was peritoneal carcinomatosis possibly due to ovarian cancer complicated by pelvic inflammatory disease. |
| PubMedID- 23334121 | peritoneal carcinomatosis in patients with ovarian cancer: enhanced ct versus 18f-fdg pet/ct. |
| PubMedID- 25430988 | Results: peritoneal carcinomatosis (pc) was due to colorectal and ovarian cancer, peritoneal mesothelioma and pseudomyxoma peritonei (pmp). |
| PubMedID- 20833850 | Cross-sectional imaging of peritoneal carcinomatosis in patients with advanced ovarian cancer is important for appropriate management but can be compromised by the small size of cancer implants and the complexity of anatomic relationships. |
| PubMedID- 20332449 | Angiogenesis in the peritoneal cavity arising from ovarian cancer leads to peritoneal carcinomatosis, malignant ascites formation, morbidity and high mortality. |
| PubMedID- 25461804 | Background: hyperthermic intraperitoneal chemotherapy (hipec) is advised as a treatment option for epithelial ovarian cancer (eoc) with peritoneal carcinomatosis. |
| PubMedID- 22101807 | Similarly, we have shown in a murine model of ovarian cancer with peritoneal carcinomatosis that plasma and, in particular, ascitic vegf levels correlate well with malignant ascites formation and that vegf inhibition dramatically halts ascites production . |
| PubMedID- 21915127 | It has been argued that conventional imaging techniques do not easily detect peritoneal carcinomatosis in patients with recurrent ovarian cancer (hopper et al, 1996; gronlund et al, 2004; ferrandina et al, 2008). |
Page: 1